These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25934414)

  • 21. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
    Greenblatt DT; Benton EC; Groves RW; Setterfield JF
    Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Pemphigus Vulgaris: Case Report.
    Arpita R; Monica A; Venkatesh N; Atul S; Varun M
    Ethiop J Health Sci; 2015 Oct; 25(4):367-72. PubMed ID: 26949302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of pemphigus vulgaris: current and emerging options.
    Yeh SW; Sami N; Ahmed RA
    Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination.
    Fernández S; España A; Navedo M; Barona L
    Br J Dermatol; 2012 Nov; 167(5):1011-6. PubMed ID: 22716123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients.
    Brown AE; Motaparthi K; Hsu S
    Dermatol Online J; 2018 Jan; 23(12):. PubMed ID: 29447653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations.
    Craythorne E; du Viver A; Mufti GJ; Warnakulasuriya S
    J Oral Pathol Med; 2011 Sep; 40(8):616-20. PubMed ID: 21385212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigus vulgaris.
    Nayak V; Kini R; Rao PK; Shetty U
    BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32404374
    [No Abstract]   [Full Text] [Related]  

  • 28. Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study.
    Mignogna MD; Leuci S; Fedele S; Ruoppo E; Adamo D; Russo G; Pagliuca R
    Am J Clin Dermatol; 2008; 9(5):323-31. PubMed ID: 18717608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemphigus vulgaris: An underdiagnosed cause of oral ulcer.
    Choudhury A; Jana T; Das S; Sinha R
    Ear Nose Throat J; 2015 Dec; 94(12):474-6. PubMed ID: 26670752
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early detection of pemphigus vulgaris: role of the dentist].
    Fiore-Donno G; Samson J
    SSO Schweiz Monatsschr Zahnheilkd; 1979 Nov; 89(11):1121-32. PubMed ID: 293902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
    Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
    Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral pemphigus].
    Jaspers GW; Jonkman MF; Vissink A
    Ned Tijdschr Tandheelkd; 2006 May; 113(5):206-8. PubMed ID: 16729567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical resolution of pemphigus vulgaris on rituximab.
    Cusick E; Silverstein D
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral mucosal disease: pemphigus.
    Scully C; Mignogna M
    Br J Oral Maxillofac Surg; 2008 Jun; 46(4):272-7. PubMed ID: 17870218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed response of oral pemphigus vulgaris to rituximab treatment.
    Niedermeier A; Wörl P; Barth S; Schuler G; Hertl M
    Eur J Dermatol; 2006; 16(3):266-70. PubMed ID: 16709491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pemphigus vulgaris: the role of the dentist in its management.
    McMurchy KA; Dick HM
    J Can Dent Assoc (Tor); 1972 Feb; 38(2):67-71. PubMed ID: 4500659
    [No Abstract]   [Full Text] [Related]  

  • 37. First line treatment of pemphigus vulgaris with a novel protocol in patients with contraindications to systemic corticosteroids and immunosuppressive agents: Preliminary retrospective study with a seven year follow-up.
    Ahmed AR; Nguyen T; Kaveri S; Spigelman ZS
    Int Immunopharmacol; 2016 May; 34():25-31. PubMed ID: 26919279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rituximab induced remission of pemphigus vulgaris: 2 cases].
    Borel C; Launay F; Garrouste C; Astudillo L; Bazex J; Arlet P; Paul C; Viraben R; Sailler L
    Rev Med Interne; 2007 Apr; 28(4):266-8. PubMed ID: 17188405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral pemphigus vulgaris in a pediatric patient.
    Anand R; Jaiswal JN; Samadi F
    J Indian Soc Pedod Prev Dent; 2010; 28(3):200-2. PubMed ID: 21157054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.